Atezolizumab Prolongs Survival in NSCLC With PD - L1 Expression

Overall survival longer than for chemotherapy in metastatic NSCLC with high PD - L1 expression
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Oncology, Pharmacy, Pulmonology, Journal, Source Type: news